Eucrates Biomedical Acquisition Stock (NASDAQ:EUCR)
Previous Close
$10.04
52W Range
$9.87 - $10.25
50D Avg
$10.11
200D Avg
$10.02
Market Cap
$42.23M
Avg Vol (3M)
$1.66K
Beta
-0.07
Div Yield
-
EUCR Company Profile
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Industry
Shell Companies
Sector
Financial Services
Exchange
NASDAQ
ADR
-
Country
US
Employees
-
IPO Date
Dec 28, 2020
Website
-